| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/19/2013 | CA2562780C Nucleic acid melting analysis with saturation dyes |
| 02/19/2013 | CA2552752C A handheld device with a disposable element for chemical analysis of multiple analytes |
| 02/19/2013 | CA2544451C Fluorescent label with polyether derived spacer |
| 02/19/2013 | CA2519557C Steroid hormone analysis by mass spectrometry |
| 02/19/2013 | CA2487137C Tumour-associated peptides that bind to mhc molecules |
| 02/19/2013 | CA2477459C Comparative field analysis (comfa) utilizing topomeric alignment of molecular fragments |
| 02/19/2013 | CA2467434C Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 02/19/2013 | CA2448382C Use of hepcidin as a regulator of iron homeostasis |
| 02/19/2013 | CA2443088C Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
| 02/19/2013 | CA2233570C Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/14/2013 | WO2013023217A1 Method of measuring and monitoring in vivo nitrite levels |
| 02/14/2013 | WO2013023215A1 Methods for sensitive and rapid detection of molecules |
| 02/14/2013 | WO2013023198A2 Rapid and sensitive detection of bacteria in blood products, urine, and other fluids |
| 02/14/2013 | WO2013023162A2 Anti-muc1 antibodies for cancer diagnostics |
| 02/14/2013 | WO2013023144A2 Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease |
| 02/14/2013 | WO2013023132A1 Diagnostic and prognostic markers for cancer |
| 02/14/2013 | WO2013022995A2 Biomarker compositions and methods |
| 02/14/2013 | WO2013022953A2 Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof |
| 02/14/2013 | WO2013022948A1 Cell lines comprising endogenous taste receptors and their uses |
| 02/14/2013 | WO2013022947A1 Cell lines comprising endogenous taste receptors and their uses |
| 02/14/2013 | WO2013022935A1 Predictors for cancer treatment |
| 02/14/2013 | WO2013022841A1 Nitrated sphingosine 1-phosphate 3 receptor as a predictor of acute lung injury-associated mortality |
| 02/14/2013 | WO2013022821A1 Antiandrogen therapy monitoring methods and compositions |
| 02/14/2013 | WO2013022789A2 Compositions and methods for assessing and determining the presence of liver cancer in a mammalian subject |
| 02/14/2013 | WO2013022786A2 Microrna biomarkers |
| 02/14/2013 | WO2013022760A1 Methods and compositions for monitoring heart failure |
| 02/14/2013 | WO2013022739A1 Modular extracellular sensor architecture for cell-based biosensors |
| 02/14/2013 | WO2013022545A1 High surface area flexible chemiresistive biosensor by oxidative chemical vapor deposition |
| 02/14/2013 | WO2013022418A1 Nondestructive method to determine crystallinity in amorphous alloy |
| 02/14/2013 | WO2013022406A1 Angiopoietin-like 4 and its use in modulating cell leakiness |
| 02/14/2013 | WO2013022322A2 Composition for mass analysis of haptoglobin and method for diagnosing cancer using same |
| 02/14/2013 | WO2013022313A2 Method for quantitatively sensing and effectively marking interaction with target material by using energy transfer and signal change based on high-density display of material |
| 02/14/2013 | WO2013022299A2 Method for inducing physiological adjustment using high density display of material |
| 02/14/2013 | WO2013022284A2 Microchip-based apparatus for examining platelet composite functions |
| 02/14/2013 | WO2013022262A2 Human resistin receptor, and use thereof |
| 02/14/2013 | WO2013022107A1 Method for pretreating biological sample containing protein |
| 02/14/2013 | WO2013022080A1 Method for assessing numbness or spontaneous pain using animal |
| 02/14/2013 | WO2013022052A1 Medicinal agent for medical applications, and method for searching for novel medicinal agent |
| 02/14/2013 | WO2013021962A1 Kit for diagnosing alzheimer's dementia by carbohydrate chain measurement of complement c3 protein, diagnostic marker, and detection method |
| 02/14/2013 | WO2013021894A1 Method and system for detecting bacteria in surgical cleaning solution |
| 02/14/2013 | WO2013021815A1 Nanopore-based analysis device |
| 02/14/2013 | WO2013021754A1 Urine component analysis device and urine component analysis method |
| 02/14/2013 | WO2013021695A1 Urine component analysis device and urine component analysis method |
| 02/14/2013 | WO2013021381A1 Method of identifying agents that affect maturation, survival and myelination |
| 02/14/2013 | WO2013021359A1 Method for dissolution testing of solid compositions containing digestive enzymes |
| 02/14/2013 | WO2013021228A1 Early childhood membranous nephropathy due to cationic bovine serum albumin |
| 02/14/2013 | WO2013021213A1 Pollution monitoring |
| 02/14/2013 | WO2013021210A1 Materials and methods for determining sensitivity potential of compounds |
| 02/14/2013 | WO2013021145A1 Improvements in or relating to catalysts |
| 02/14/2013 | WO2013021129A2 Use of a cb1 receptor antagonist as a whitening and/or anti-browning agent for keratin material |
| 02/14/2013 | WO2013021128A2 Use of cannabinoid compounds for stimulating melanogenesis |
| 02/14/2013 | WO2013021125A1 Predictive h2s model using x-ray absorption spectroscopy |
| 02/14/2013 | WO2013021101A1 Method and apparatus for automated analysis |
| 02/14/2013 | WO2013021088A2 Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas |
| 02/14/2013 | WO2013021057A2 Method of neonatal serological diagnosis |
| 02/14/2013 | WO2013021035A1 Microfluids for cell-based assays |
| 02/14/2013 | WO2013020988A1 Pasteurellaceae vaccines |
| 02/14/2013 | WO2013020690A1 Predicting response to anti-cd20 therapy in dlbcl patients |
| 02/14/2013 | WO2013020607A1 Early childhood membranous nephropathy due to cationic bovine serum albumin |
| 02/14/2013 | WO2013020557A1 Method and antibodies for the identification of ubiquitinated proteins and sites of ubiquitination |
| 02/14/2013 | WO2013020235A1 Methods and compositions for modulating voltage-gated calcium channel function |
| 02/14/2013 | WO2013020201A1 Diagnostic methods and kits for monitoring response to chemotherapy in ovarian cancer |
| 02/14/2013 | WO2012176977A3 Microscope apparatus for detecting or imaging protein using ifret probe, and method for detecting or imaging protein using same |
| 02/14/2013 | WO2012175741A3 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| 02/14/2013 | WO2012165783A3 Thermal combustion total organic carbon content measuring device without a catalyst and using a ceramic ball |
| 02/14/2013 | WO2012155019A8 Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature peptides |
| 02/14/2013 | WO2012148297A4 Method for determining skin sensitisation potential |
| 02/14/2013 | WO2012142568A9 Remote transmission of electromagnetic signals inducing nanostructures amplifiable into a specific dna sequence |
| 02/14/2013 | WO2012115493A9 Biomarker for cancer, and cancer diagnosis using same |
| 02/14/2013 | US20130042333 Markers for cancer prognosis and therapy and methods of use |
| 02/14/2013 | US20130041691 Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system |
| 02/14/2013 | US20130041236 Sample analysis system and method of use |
| 02/14/2013 | US20130041019 SDF-1 Binding Nucleic Acids |
| 02/14/2013 | US20130041016 Compositions and Methods for Preventing and Treating Cancer via Modulating UBE1L, ISG215 and/or UBP43 |
| 02/14/2013 | US20130041015 Use of the Lactosylceramide Synthase Isoform B1,4GALT-V as a Biomarker for Cancer |
| 02/14/2013 | US20130041013 Isoform of bruton's tyrosine kinase (btk) protein |
| 02/14/2013 | US20130041012 New isoform of bruton's tyrosine kinase (btk) protein |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130040952 Influenza virus inhibitors that disrupt nucleoprotein trimerization |
| 02/14/2013 | US20130040912 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders |
| 02/14/2013 | US20130040906 Inhibitors of Human EZH2, and Methods of Use Thereof |
| 02/14/2013 | US20130040881 Ltbp2 as a biomarker for renal dysfunction |
| 02/14/2013 | US20130040851 Evaluation Method for Arteriosclerosis |
| 02/14/2013 | US20130040850 Serology assays |
| 02/14/2013 | US20130040849 Method and kit for cancer diagnosis |
| 02/14/2013 | US20130040845 Method for screening receptors/ligands interactions |
| 02/14/2013 | US20130040844 Biomarkers of aging for detection and treatment of disorders |
| 02/14/2013 | US20130040839 Method for Diagnosing or Determining the Prognosis of Colorectal Cancer (CRC) Using Novel Autoantigens: Gene Expression Guided Autoantigen Discovery |
| 02/14/2013 | US20130040836 Methods for engineering t-cell receptors |
| 02/14/2013 | US20130040834 Sample plate systems and methods |
| 02/14/2013 | US20130040830 Fluid Sample Testing System |
| 02/14/2013 | US20130040407 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING |
| 02/14/2013 | US20130040406 Device for Preparing And/Or Treating a Biological Sample |
| 02/14/2013 | US20130040405 Methods for sensitive and rapid detection of molecules |
| 02/14/2013 | US20130040403 Method and apparatus for automated analysis |
| 02/14/2013 | US20130040374 Chemical sensor |
| 02/14/2013 | US20130040325 Enzyme Linked Immunosorbent Assay (ELISA) Method and Kit for Detecting Soluble Programmed Cell Death Protein 5 (PDCD5) |
| 02/14/2013 | US20130040324 Perifusion device |
| 02/14/2013 | US20130040323 DETECTION KIT CONTAINING A NOVEL RECOMBINANT 15-kDA POLYPEPTIDE USEFUL FOR DETECTING HUMAN INFECTION WITH BARTONELLA HENSELAE |
| 02/14/2013 | US20130040322 Method of Diagnosing Sjogren's Disease |